Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Boston Scientific Corporation

Capitalization 134B 127B 118B 106B 188B 11,323B 206B 1,468B 545B 4,636B 502B 491B 19,978B P/E ratio 2024 *
68x
P/E ratio 2025 * 47.9x
Enterprise value 141B 134B 125B 111B 197B 11,914B 217B 1,545B 573B 4,878B 528B 516B 21,021B EV / Sales 2024 *
8.48x
EV / Sales 2025 * 7.38x
Free-Float
84.69%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.25%
1 week+0.48%
Current month-0.25%
1 month+8.14%
3 months+10.56%
6 months+19.66%
Current year+56.43%
More quotes
1 week
89.10
Extreme 89.1
91.34
1 month
83.55
Extreme 83.55
91.93
Current year
57.11
Extreme 57.11
91.93
1 year
53.93
Extreme 53.93
91.93
3 years
34.98
Extreme 34.98
91.93
5 years
24.10
Extreme 24.1
91.93
10 years
12.56
Extreme 12.56
91.93
More quotes
Director TitleAgeSince
Chief Executive Officer 59 2011-10-31
Director of Finance/CFO 58 2013-12-30
Chief Tech/Sci/R&D Officer - 2009-08-31
Manager TitleAgeSince
Director/Board Member 59 2009-03-31
Chairman 59 2016-05-02
Director/Board Member 72 2014-02-28
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.25%+0.48%+61.08%+137.10%134B
+0.06%+3.25%+6.82%-15.36%203B
+0.16%-0.92%+72.22%+69.68%193B
+0.67%+2.31%+7.97%-24.53%173B
+0.97%+4.06%-2.52%-20.28%60.6B
+1.04%-0.04%-9.27%-26.59%43.5B
-1.15%+0.07%+3.17%-34.35%42.08B
+1.17%+4.29%+8.38%-5.82%39.35B
-0.17%+0.78%+19.69% - 38.02B
-1.65%+0.47%+53.42%-3.30%36.54B
Average +0.09%+1.37%+22.10%+8.50% 96.25B
Weighted average by Cap. +0.17%+1.29%+28.54%+21.88%
See all sector performances

Financials

2024 *2025 *
Net sales 16.58B 15.79B 14.69B 13.1B 23.28B 1,405B 25.61B 182B 67.62B 575B 62.23B 60.9B 2,479B 18.62B 17.74B 16.51B 14.72B 26.15B 1,578B 28.76B 205B 75.96B 646B 69.9B 68.4B 2,784B
Net income 1.98B 1.88B 1.75B 1.56B 2.78B 168B 3.05B 21.72B 8.06B 68.59B 7.42B 7.26B 296B 2.84B 2.71B 2.52B 2.25B 3.99B 241B 4.39B 31.24B 11.6B 98.65B 10.67B 10.44B 425B
Net Debt 6.98B 6.64B 6.18B 5.51B 9.79B 591B 10.77B 76.64B 28.45B 242B 26.18B 25.62B 1,043B 3.89B 3.71B 3.45B 3.08B 5.47B 330B 6.01B 42.78B 15.88B 135B 14.62B 14.3B 582B
More financial data * Estimated data
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%); - endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ; - neuromodulation (2%). The United States account for 59.2% of net sales.
Employees
48,000
More about the company
Date Price Change Volume
24-12-02 90.43 $ -0.25% 3,387,968
24-11-29 90.66 $ -0.10% 3,446,971
24-11-27 90.75 $ +0.60% 3,788,570
24-11-26 90.21 $ +1.08% 4,284,463

Delayed Quote Nyse, December 02, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart BOSTON-SCIENTIFIC-CORPORAMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
90.66USD
Average target price
97.00USD
Spread / Average Target
+6.99%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW